Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Health and economic impact of surgical site infections diagnosed after hospital discharge.

Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R.

Emerg Infect Dis. 2003 Feb;9(2):196-203.

2.

The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost.

Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ.

Infect Control Hosp Epidemiol. 2002 Apr;23(4):183-9.

PMID:
12002232
3.

Costs Associated With Surgical Site Infections in Veterans Affairs Hospitals.

Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS.

JAMA Surg. 2014 Jun;149(6):575-81. doi: 10.1001/jamasurg.2013.4663.

PMID:
24848779
4.

Cost and quality of life outcome analysis of postoperative infections after subaxial dorsal cervical fusions.

Kuhns BD, Lubelski D, Alvin MD, Taub JS, McGirt MJ, Benzel EC, Mroz TE.

J Neurosurg Spine. 2015 Apr;22(4):381-6. doi: 10.3171/2014.10.SPINE14228. Epub 2015 Jan 23.

PMID:
25615630
5.

Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.

Berman S, Rannie M, Moore L, Elias E, Dryer LJ, Jones MD Jr.

Pediatrics. 2005 Jun;115(6):e637-42.

PMID:
15930189
6.

Health care resource use associated with integrated psychological treatment.

Vasiliadis HM, Briand C, Lesage A, Reinharz D, Stip E, Nicole L, Lalonde P.

J Ment Health Policy Econ. 2006 Dec;9(4):201-7.

PMID:
17200597
7.

The economic costs of surgical site infection.

Fry DE.

Surg Infect (Larchmt). 2002;3 Suppl 1:S37-43. Review.

PMID:
12573038
8.

Comparative analysis of perioperative surgical site infection after minimally invasive versus open posterior/transforaminal lumbar interbody fusion: analysis of hospital billing and discharge data from 5170 patients.

McGirt MJ, Parker SL, Lerner J, Engelhart L, Knight T, Wang MY.

J Neurosurg Spine. 2011 Jun;14(6):771-8. doi: 10.3171/2011.1.SPINE10571. Epub 2011 Mar 18.

PMID:
21417699
9.

The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ.

Infect Control Hosp Epidemiol. 1999 Nov;20(11):725-30.

PMID:
10580621
10.

Surgical site infection: incidence and impact on hospital utilization and treatment costs.

de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB.

Am J Infect Control. 2009 Jun;37(5):387-97. doi: 10.1016/j.ajic.2008.12.010. Epub 2009 Apr 23.

PMID:
19398246
11.

Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006.

Birnbaum HG, Pike C, Banerjee R, Waldman T, Cifaldi M.

Pharmacoeconomics. 2012 Apr;30(4):323-36. doi: 10.2165/11589470-000000000-00000.

PMID:
22379953
12.

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.

PMID:
19948302
13.

Predictors of costs of caring for elderly patients discharged with heart failure.

Wexler DJ, Chen J, Smith GL, Radford MJ, Yaari S, Bradford WD, Krumholz HM.

Am Heart J. 2001 Aug;142(2):350-7.

PMID:
11479477
14.

Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective.

Granados-García V, Velázquez-Castillo R, Garduño-Espinosa J, Torres-López J, Muñoz-Hernández O.

Rev Invest Clin. 2009 Jan-Feb;61(1):18-25.

PMID:
19507471
15.

Pediatric short-bowel syndrome: the cost of comprehensive care.

Spencer AU, Kovacevich D, McKinney-Barnett M, Hair D, Canham J, Maksym C, Teitelbaum DH.

Am J Clin Nutr. 2008 Dec;88(6):1552-9. doi: 10.3945/ajcn.2008.26007.

17.

Financial impact of surgical site infections on hospitals: the hospital management perspective.

Shepard J, Ward W, Milstone A, Carlson T, Frederick J, Hadhazy E, Perl T.

JAMA Surg. 2013 Oct;148(10):907-14. doi: 10.1001/jamasurg.2013.2246.

PMID:
23965750
18.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
19.

Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina.

Christensen MC, Previgliano I, Capparelli FJ, Lerman D, Lee WC, Wainsztein NA.

Acta Neurol Scand. 2009 Apr;119(4):246-53. doi: 10.1111/j.1600-0404.2008.01094.x. Epub 2008 Sep 1.

PMID:
18771525
20.

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.

Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J.

J Fam Pract. 1998 Dec;47(6):446-52.

PMID:
9866670

Supplemental Content

Support Center